ArticleFrontiers in oncology2022

Synergistic effects of nab-PTX and anti-PD-1 antibody combination against lung cancer by regulating the Pi3K/AKT pathway through the

Jun Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.